Ovarian cancer

The main articles are:

• Cancer (cancer)
• Malignant diseases of the reproductive system

Ovarian cancer (OC) ranks 8th among cancers diagnosed in women around the world and 9th in Russia^[1]. In Russia, from 2008 to 2018, there was a clear trend towards an increase in the incidence of OC - the increase in incidence rates was 10.19%. The number of OC cases in 2018 reached 14,318 new cases, with an incidence of 18.9 cases per 100,000 female population.

Ovarian cancer accounts for more deaths than other gynecological malignancies, as in most cases the tumor is detected when the cancer has already spread beyond the ovaries. In 2018, 7,616 women died from OC, accounting for 34% of deaths from female genital malignancies and 5.5% of all malignancies in the female population.

Genetic predisposition

Malignant diseases of the reproductive system (including breast ovarian cancer) can be genetically determined and associated with mutations in the BRCA1, BRCA2 and other genes that can be inherited. According to data available for November 2020, in ovarian cancer, mutations in BRCA1/2 genes are detected in 22-28% of cases. Read more here.

Ovarian cancer treatment

Main article: Treatment of ovarian cancer

2021: Launch of online test to detect breast and ovarian cancer risk

On September 8, 2021, the biopharmaceutical company AstraZeneca announced that, together with the service of online consultations of doctors and medical support of patients, RT-Doctis, has developed an online test with which women can independently check for risk factors for breast cancer (BC) and ovarian cancer (OC). According to the test results, women who are at risk can receive telemedicine advice and, if necessary, be examined by a specialized specialist. Read more here.